Search Orphan Drug Designations and Approvals
-
| Generic Name: | fully human IgG2 monoclonal antibody that blocks interleukin-1 receptor 1 |
|---|---|
| Date Designated: | 10/16/2025 |
| Orphan Designation: | treatment of pericarditis |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Kiniksa Pharmaceuticals,GmbH,c/o Kiniksa Pharmaceuticals Corp 100 Hayden Avenue Lexington, Massachusetts 02421 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







